At Home Infectious Disease Testing & the Power of Innovation

Play Video

(Video 2:11)

Personal video message to GRIP friends and family

Transcript

“Hey folks Ed Gillen here, CEO of GRIP Molecular.

I’m in the beautiful Appalachian Mountains near a stream that’s close to my home.

Like this stream innovation is constantly flowing, it’s constantly altering the terrain around us, it has awesome power.

At GRIP Molecular we intend to harness the power of innovation and to channel it -together- to transform medical diagnostics.

GRIP Mission/Vision

— We will bring together the power of innovative technologies like digital health, tele-communication and graphene (the new wonder material [graphene] of this last decade)

— We will apply it all to an electronic biosensor that can provide very rapid and broad diagnostic results in minutes.

— We will put that power into your hands.

— We will enable all of us – as consumers- of this technology – to take those diagnostic results, share them as we wish with our clinicians, to engage them in the process of thinking about those diagnostic results and to give them the opportunity with that diagnostic information to recommend appropriate therapy, so it can be rapidly applied when it is most valuable.

— We will be able to do all that virtually, so we don’t require a visit to see the doctor in person at a clinic where all the other sick people are (probably the last place that we would want to be when we’re in fact sick)

Wrapping it up

We will harness this power of new technologies, bring them together, put those technologies into your hands and in so doing transform medical diagnostics and enhance healthcare.

Well, that’s what we’re doing at GRIP Molecular. 

We do so appreciate your support of the company. 

Go GRIP! 

Please don’t hesitate to reach out to us if you’d like to learn more about GRIP Molecular.”

Thank You 

Edward Gillen

Ps; Happy 4th of July

Stasia Ogden, JD

Stasia Ogden recently joined GRIP in a General Counsel role with a particular expertise in Intellectual Property Law.  Stasia has over 20 years as a practicing attorney in law firms and major multi-national corporations and 9 years with Baxter Healthcare Corporation and 4 years with BD.  Her focus on healthcare industry global IP strategy, transactions, licensing, litigation and global portfolio management will help GRIP navigate global IP issues and maximize existing rights to 3+ patent families that provide the foundation for GRIP’s novel electronic biosensor.  Stasia has a Juris Doctor degree from Georgetown University, an MBA from University of Missouri – St. Louis, and a BA in Biochemistry from Northwestern University in Chicago.

Michael Osterholm PhD

University of Minnesota Regents Professor 
  • McKnight Presidential Endowed Chair in Public Health 
  • Author
  • University of Minnesota
  • Director of the Center for Infectious Disease Research and Policy (CIDRAP)
  • Distinguished Teaching Professor in the Division of Environmental Health Sciences, School of Public Health and Technological Leadership Institute, College of Science and Engineering,
  • Medical School – Adjunct Professor
  • Science Envoy for Health Security on behalf of the US Department of State 2018-19
  • Numerous national/global Advisory Board appointments on Biosecurity, Health Research and Pandemics

Steven Koester PhD

Professor Electrical & Computer Engineering
University of Minnesota

Research Areas:

  • Graphene Biosensors
  • Biomedical & Biological Computational Methods
  • Energy Systems & Power Electronics
  • Micro and Nano structures 

Michael McAlpine, PhD

Professor Mechanical Engineering University of Minnesota

Research Areas:

  • 3D printing functional materials & devices
  • Advanced manufacturing using nanoscale inks
  • Biomedical devices
  • Bioelectronics

Edward Ludwig

  • 45+years of senior executive medical industry leadership experience
  •   Numerous Board roles, including with; Boston Scientific, CVS, Aetna, AdvaMed (Chairman), Johns Hopkins Michael Bloomberg School of Public Health, Hackensack University Medical Center, College of Holy Cross, Columbia Business School, The Center for Higher Ambition Leadership 
  • MBA – Columbia University

Laurie Knutson MBA

Vice President of Marketing

Laurie Knutson is GRIP’s VP of Marketing.  She bring over 30 years of healthcare strategy, product development and systems transformation experience across Fortune 50 to pre-revenue companies. Laurie has held C-level roles healthcare services, products, insurance, financial services and consulting, and was founder or C-level at 4 tech startups.  Laurie’s focus on commercializing products in the healthcare sector is based on her unique ability to assess the market and product adoption variables in areas of unmet needs. Laurie also has 10+ years analytics with care model development for seniors, commercial and vulnerable populations.  Laurie has her MBA in Finance from the University of Minnesota and her BA in Biology from St. Olaf College in Northfield, Minnesota.

Richard G Minicus MBA, MS

Rich Minicus is seasoned Chief Financial Officer with over 30 years in M&A, venture capital investment, and capital markets transactions. Rich brings 21 years in medical technology business development with Becton Dickinson, BD Ventures, and Pfizer which has enabled GRIP to quickly formulate a detailed financial plan beyond what most startups provide to investors. Rich also has 9 years in finance with Merrill Lynch Capital Markets, ML Venture Capital, and JP Morgan. Rich earned his MBA at Harvard Business School, and holds a MS in Biology from Fairleigh Dickinson University.

Caroline Popper

Caroline Popper, MD is the Co-Founder and President, Popper & Co. healthcare consultancy. Caroline has the perfect combination of 30 years’ experience in medical diagnostics and drug discovery, combined with extensive direct clinical experience. She has held many senior managerial and advisory positions with numerous global diagnostics companies, including BD, bioMérieux and MDS Proteomics. Caroline was also an attending physician at the Department of Emergency Medicine at Baltimore’s Johns Hopkins Hospital, where she completed residencies in internal medicine and pathology.

Edward Gillan

CEO, CCO

Ed Gillen is GRIP’s CEO and brings over 30 years medical device industry experience, including point-of-care diagnostics.  Ed enjoyed a successful 23-year career at Becton Dickinson (BD) holding many positions globally including WW Senior Director – Strategy & Business Development – Diabetes Care Division, Global VP/GM – Surgical and Anesthesia Systems ($200M P&L), Advanced Drug Delivery, Global Business Leader – Vaccine Delivery.  Ed’s startup experience includes his most recent role as CEO Medality Medical. Ed has his MBA from Penn State University.

disease diagnosis Grip molecular

Bruce Batten

Founder/Chairman/President

Bruce Batten has been founder / CEO of four technology startups including C-level roles at Thermo Instruments, CyberOptics and Advantek. Bruce started his career in Academia earning a Ph.D. in Anatomy & Cell Biology at the Medical College of Virginia, post-doctoral work at Harvard Medical School. He was Faculty member at Harvard, Tufts and The Ohio State medical schools and later ran the MBA Program at Augsburg University. Bruce has over 10 years of molecular diagnostic development, including detailed work on a POC Zika virus assay. Bruce founded GRIP Molecular to commercialize breakthrough solid state bioelectronic technology that will disrupt the diagnostic industry and empower consumers and doctors with fast, accurate and comprehensive information.

Linkedin